Sigilon Therapeutics Stock Market Capitalization
| SGTXDelisted Stock | USD 21.11 0.33 1.54% |
Sigilon Therapeutics fundamentals help investors to digest information that contributes to Sigilon Therapeutics' financial success or failures. It also enables traders to predict the movement of Sigilon Stock. The fundamental analysis module provides a way to measure Sigilon Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sigilon Therapeutics stock.
Sigilon |
Sigilon Therapeutics Company Market Capitalization Analysis
Sigilon Therapeutics' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Sigilon Therapeutics Market Capitalization | 56.22 M |
Most of Sigilon Therapeutics' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sigilon Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Sigilon Therapeutics is about 56.22 M. This is 99.57% lower than that of the Biotechnology sector and 98.81% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.7% higher than that of the company.
Sigilon Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sigilon Therapeutics' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sigilon Therapeutics could also be used in its relative valuation, which is a method of valuing Sigilon Therapeutics by comparing valuation metrics of similar companies.Sigilon Therapeutics is currently under evaluation in market capitalization category among its peers.
Sigilon Fundamentals
| Return On Equity | -0.76 | |||
| Return On Asset | -0.24 | |||
| Profit Margin | (1.71) % | |||
| Operating Margin | (1.75) % | |||
| Current Valuation | 28.99 M | |||
| Shares Outstanding | 2.5 M | |||
| Shares Owned By Insiders | 8.69 % | |||
| Shares Owned By Institutions | 54.33 % | |||
| Number Of Shares Shorted | 8.23 K | |||
| Price To Book | 0.25 X | |||
| Price To Sales | 0.87 X | |||
| Revenue | 12.94 M | |||
| Gross Profit | (24.69 M) | |||
| EBITDA | (41.27 M) | |||
| Net Income | (43.56 M) | |||
| Cash And Equivalents | 88.21 M | |||
| Cash Per Share | 2.72 X | |||
| Total Debt | 28.06 M | |||
| Debt To Equity | 0.61 % | |||
| Current Ratio | 2.77 X | |||
| Book Value Per Share | 10.97 X | |||
| Cash Flow From Operations | (51.47 M) | |||
| Short Ratio | 0.11 X | |||
| Earnings Per Share | (14.83) X | |||
| Target Price | 47.33 | |||
| Number Of Employees | 62 | |||
| Beta | 4.12 | |||
| Market Capitalization | 56.22 M | |||
| Total Asset | 87.28 M | |||
| Retained Earnings | (256.8 M) | |||
| Working Capital | 43.42 M | |||
| Z Score | -3.73 | |||
| Net Asset | 87.28 M |
About Sigilon Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sigilon Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sigilon Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sigilon Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Sigilon Stock
If you are still planning to invest in Sigilon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sigilon Therapeutics' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |